{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:50:59Z","timestamp":1759402259600},"reference-count":36,"publisher":"Elsevier BV","issue":"25","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.vaccine.2007.03.050","type":"journal-article","created":{"date-parts":[[2007,4,21]],"date-time":"2007-04-21T11:10:21Z","timestamp":1177153821000},"page":"4828-4836","source":"Crossref","is-referenced-by-count":18,"title":["Immunogenicity and protective efficacy offered by a ribosomal-based vaccine from Shigella flexneri 2a"],"prefix":"10.1016","volume":"25","author":[{"given":"Doo-Hee","family":"Shim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun-Young","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Moo","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodney","family":"Carbis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecil","family":"Czerkinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Uematsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shizuo","family":"Akira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi-Na","family":"Kweon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2007.03.050_bib1","first-page":"133","article-title":"Shigellosis","volume":"43","author":"Niyogi","year":"2005","journal-title":"J Microbiol"},{"issue":"12","key":"10.1016\/j.vaccine.2007.03.050_bib2","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nri1499","article-title":"War and peace at mucosal surface","volume":"4","author":"Sansonetti","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2007.03.050_bib3","series-title":"Fundamental Immunology","first-page":"909","article-title":"The mucosal immune system","author":"McGhee","year":"1999"},{"issue":"4","key":"10.1016\/j.vaccine.2007.03.050_bib4","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Czerkinsky","year":"2005","journal-title":"Nature Med"},{"issue":"8","key":"10.1016\/j.vaccine.2007.03.050_bib5","first-page":"651","article-title":"Global burden of Shigella infections: implications for vaccine development and implementation of control strategies","volume":"77","author":"Kotloff","year":"1999","journal-title":"Bull World Health Organ"},{"issue":"3","key":"10.1016\/j.vaccine.2007.03.050_bib6","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1128\/IAI.69.3.1351-1357.2001","article-title":"Safety and immunogenicity of improved Shigella O-specific polysaccharide-protein conjugate vaccines in adults in Israel","volume":"69","author":"Passwell","year":"2001","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2007.03.050_bib7","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1128\/IAI.67.7.3437-3443.1999","article-title":"Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602","volume":"67","author":"Coster","year":"1999","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2007.03.050_bib8","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1128\/IAI.72.2.923-930.2004","article-title":"Two studies evaluating the safety and immunogenicity of a live, attenuated Shigella flexneri 2a vaccine (SC602) and excretion of vaccine organisms in North American volunteers","volume":"72","author":"Katz","year":"2004","journal-title":"Infect Immun"},{"issue":"18","key":"10.1016\/j.vaccine.2007.03.050_bib9","first-page":"3728","article-title":"Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model","volume":"24","author":"Berry","year":"2006","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2007.03.050_bib10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/clinids\/8.2.208","article-title":"Microbial ribosomal vaccines","volume":"8","author":"Gregory","year":"1986","journal-title":"Rev Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2007.03.050_bib11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000234644","article-title":"Parenteral immunization with Shigella ribosomal vaccine elicits local IgA response and primes for mucosal memory","volume":"87","author":"Levenson","year":"1988","journal-title":"Int Arch Aller Appl Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2007.03.050_bib12","first-page":"60","article-title":"Ribosomal dysentery vaccine. I. Method of production, physical and chemical properties","author":"Levenson","year":"1978","journal-title":"Zh Mikrobiol Epidemiol Immunobiol"},{"issue":"9","key":"10.1016\/j.vaccine.2007.03.050_bib13","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1086\/344526","article-title":"A nontoxic chimeric enterotoxin adjuvant induces protective immunity in both mucosal and systemic compartments with reduced IgE antibodies","volume":"186","author":"Kweon","year":"2002","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2007.03.050_bib14","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1073\/pnas.94.10.5267","article-title":"A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity","volume":"94","author":"Yamamoto","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.vaccine.2007.03.050_bib15","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.4049\/jimmunol.170.4.1754","article-title":"Protective mucosal immunity in aging is associated with functional CD4+ T cells in nasopharyngeal-associated lymphoreticular tissue","volume":"170","author":"Hagiwara","year":"2003","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.03.050_bib16","doi-asserted-by":"crossref","first-page":"762","DOI":"10.4049\/jimmunol.173.2.762","article-title":"Role of gut-associated lymphoreticular tissues in antigen-specific intestinal IgA immunity","volume":"173","author":"Yamamoto","year":"2004","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2007.03.050_bib17","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.4049\/jimmunol.174.7.4365","article-title":"Prenatal blockage of lymphotoxin \u03b2 receptor and TNF receptor p55 signaling cascade resulted in the acceleration of tissue genesis for isolated lymphoid follicles in the large intestine","volume":"174","author":"Kweon","year":"2005","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2007.03.050_bib18","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1128\/IAI.63.6.2382-2386.1995","article-title":"Intransal or intragastric immunization with proteosome-Shigella lipopolysaccharide vaccines protects against lethal pneumonia in a murine model of Shigella infection","volume":"63","author":"Mallett","year":"1995","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2007.03.050_bib19","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri1391","article-title":"Toll-like receptor signalling","volume":"4","author":"Akira","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.03.050_bib20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1084\/jem.20052093","article-title":"Innate secretory antibodies protect against natural Salmonella typhimurium infection","volume":"203","author":"Wijburg","year":"2006","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.vaccine.2007.03.050_bib21","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1128\/iai.29.2.489-493.1980","article-title":"Polyvalent antisera to Pseudomonas ribosomal vaccines: protection of mice against clinically isolated strains","volume":"29","author":"Lieberman","year":"1980","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2007.03.050_bib22","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/BF01642553","volume":"254","author":"Serrano","year":"1997","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"6","key":"10.1016\/j.vaccine.2007.03.050_bib23","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0923-2508(90)90065-X","article-title":"Polysaccharide nature of O antigen in protective ribosomal preparations from Shigella: experimental evidence and implications for the ribosomal vaccine concept","volume":"141","author":"Levenson","year":"1990","journal-title":"Res Microbiol"},{"issue":"11","key":"10.1016\/j.vaccine.2007.03.050_bib24","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.it.2004.09.005","article-title":"Let's go mucosal: communication on slippery ground","volume":"25","author":"Brandtzaeg","year":"2004","journal-title":"Trends Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.03.050_bib25","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1348-0421.2005.tb03714.x","article-title":"Facilitated production of secretory IgA against Shiga toxin B subunits by intranasal application of antigen-coated polystyrene microspheres","volume":"49","author":"Kurohane","year":"2005","journal-title":"Microbiol Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2007.03.050_bib26","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.4049\/jimmunol.178.4.2476","article-title":"New animal model of shigellosis in the Guinea pig: its usefulness for protective efficacy studies","volume":"178","author":"Shim","year":"2007","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2007.03.050_bib27","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.4049\/jimmunol.173.6.4197","article-title":"IL-8 is a key chemokine regulating neutrophil recruitment in a new mouse model of Shigella-induced colitis","volume":"173","author":"Singer","year":"2004","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2007.03.050_bib28","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1128\/IAI.69.5.3240-3247.2001","article-title":"Shigella infection in a SCID mouse-human intestinal xenograft model: role for neutrophils in containing bacterial dissemination in human intestine","volume":"69","author":"Zhang","year":"2001","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2007.03.050_bib29","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.4049\/jimmunol.166.4.2444","article-title":"Microbial lipopeptides stimulate dendritic cell maturation via Toll-like receptor 2","volume":"166","author":"Hertz","year":"2001","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.03.050_bib30","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1128\/IAI.74.1.694-702.2006","article-title":"A bacterial flagellin, Vibrio vulnificus FlaB, has a strong mucosal adjuvant activity to induce protective immunity","volume":"74","author":"Lee","year":"2006","journal-title":"Infect Immun"},{"issue":"7066","key":"10.1016\/j.vaccine.2007.03.050_bib31","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nature04267","article-title":"Control of B-cell responses by Toll-like receptors","volume":"438","author":"Pasare","year":"2005","journal-title":"Nature"},{"issue":"5807","key":"10.1016\/j.vaccine.2007.03.050_bib32","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1126\/science.1135299","article-title":"Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling","volume":"314","author":"Gavin","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2007.03.050_bib33","first-page":"79","article-title":"Ribosomes as carriers for antigenic determinants of the surface of micro-orgamisms","volume":"77","author":"Normier","year":"1992","journal-title":"Dev Biol Stand"},{"issue":"1","key":"10.1016\/j.vaccine.2007.03.050_bib34","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1128\/JB.100.1.140-148.1969","article-title":"Isolation and partial characterization of an immunogenic moiety obtained from Salmonella typhimurium","volume":"100","author":"Venneman","year":"1969","journal-title":"J Bacteriol"},{"issue":"4","key":"10.1016\/j.vaccine.2007.03.050_bib35","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1574-6968.1991.tb04219.x","article-title":"Requirement of the conformational stability of a Salmonella ribosomal vaccine for its mouse protection","volume":"3","author":"Kita","year":"1991","journal-title":"FEMS Microbiol Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.03.050_bib36","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1128\/JB.99.1.42-50.1969","article-title":"Factors affecting immunogenic activity of mycobacterial ribosomal and ribonucleic acid preparations","volume":"99","author":"Youmans","year":"1969","journal-title":"J Bacteriol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07004057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07004057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T19:45:25Z","timestamp":1628797525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07004057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":36,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0264410X07004057"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.03.050","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}